Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats

Journal of Endocrinology

Volumn 231, Issue 1, 2016, Pages 81-95

  Pongkan, Wanpitak ^a,b   Pintana, Hiranya ^a   Jaiwongkam, Thidarat ^a,b   Kredphoo, Sasiwan ^a,b   Sivasinprasasn, Sivaporn ^a,b   Chattipakorn, Siriporn C ^a,b   Chattipakorn, Nipon ^a,b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Cardiac mitochondrial function; Dipeptidyl peptidase 4 inhibitors; Ischemia reperfusion; Obese testosterone deprivation

Indexed keywords

CONNEXIN 43; TESTOSTERONE; VILDAGLIPTIN; ADAMANTANE; ANDROGEN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; NITRILE; PYRROLIDINE DERIVATIVE;

ANDROGEN DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; DRUG EFFICACY; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MITOCHONDRION; HEART PROTECTION; HEART RATE VARIABILITY; INSULIN RESISTANCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID DIET; MALE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; OBESITY; ORCHIECTOMY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; ANALOGS AND DERIVATIVES; ANIMAL; COMBINATION DRUG THERAPY; DRUG EFFECTS; HEART; HEART RATE; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; WISTAR RAT;

ADAMANTANE; ANDROGENS; ANIMALS; DIET, HIGH-FAT; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG THERAPY, COMBINATION; HEART; HEART RATE; INSULIN RESISTANCE; MALE; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; NITRILES; OBESITY; ORCHIECTOMY; PYRROLIDINES; RATS; RATS, WISTAR; TESTOSTERONE; VENTRICULAR FUNCTION, LEFT;

EID: 84991497391     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-16-0232     Document Type: Article

References (54)

1. Aon MA, Cortassa S, Akar FG, Brown DA, Zhou L & O'Rourke B 2009 From mitochondrial dynamics to arrhythmias. International Journal of Biochemistry and Cell Biology 41 1940-1948. (doi:10.1016/j.biocel.2009.02.016).
2. Apaijai N, Pintana H, Chattipakorn SC & Chattipakorn N 2012 Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet. Endocrinology 153 3878-3885. (doi:10.1210/en.2012-1262).
3. Apaijai N, Chinda K, Palee S, Chattipakorn S & Chattipakorn N 2014 Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obeseinsulin resistant rats. PLoS ONE 9 e102374. (doi:10.1371/journal. pone.0102374).
4. Appleton DJ, Rand JS & Sunvold GD 2005 Basal plasma insulin and homeostasis model assessment (HOMA) are indicators of insulin sensitivity in cats. Journal of Feline Medicine and Surgery 7 183-193. (doi:10.1016/j.jfms.2004.12.002).
5. Avila Dde L, Araujo GR, Silva M, Miranda PH, Diniz MF, Pedrosa ML, Silva ME, de Lima WG & Costa DC 2013 Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats. Archives of Medical Research 44 194-202. (doi:10.1016/j.arcmed.2013.03.004).
6. Barreto-Vianna AR, Aguila MB & Mandarim-de-Lacerda CA 2016 Effects of liraglutide in hypothalamic arcuate nucleus of obese mice. Obesity 24 626-633. (doi:10.1002/oby.21387).
7. Bayram F, Elbuken G, Korkmaz C, Aydogdu A, Karaca Z & Cakir I 2016 The effects of gonadotropin replacement therapy on metabolic parameters and body composition in men with idiopathic hypogonadotropic hypogonadism. Hormone and Metabolic Research 48 112-117. (doi:10.1055/s-0035-1564252).
8. Bertolo A, Baur M, Aebli N, Ferguson SJ & Stoyanov J 2014 Physiological testosterone levels enhance chondrogenic extracellular matrix synthesis by male intervertebral disc cells in vitro, but not by mesenchymal stem cells. Spine Journal 14 455-468. (doi:10.1016/j.spinee.2013.10.018).
9. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA et al. 2010 Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 121 2331-2378. (doi:10.1161/CIR.0b013e3181dbece1).
10. Chattipakorn N, Incharoen T, Kanlop N & Chattipakorn S 2007 Heart rate variability in myocardial infarction and heart failure. International Journal of Cardiology 120 289-296. (doi:10.1016/j.ijcard.2006.11.221).
11. Chinda K, Sanit J, Chattipakorn S & Chattipakorn N 2014 Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart. Diabetes & Vascular Disease Research 11 75-83. (doi:10.1177/1479164113516134).
12. Cornoldi A, Caminiti G, Marazzi G, Vitale C, Patrizi R, Volterrani M, Miceli M, Fini M, Spera G & Rosano G 2009 Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease. International Journal of Cardiology 142 50-55. (doi:10.1016/j.ijcard.2008.12.107).
13. Culic V & Busic Z 2015 Testosterone may influence left ventricular diastolic function depending on previous myocardial infarction and smoking. International Journal of Cardiology 186 67-71. (doi:10.1016/j.ijcard.2015.03.238).
14. Curtis MJ, Hancox JC, Farkas A, Wainwright CL, Stables CL, Saint DA, Clements-Jewery H, Lambiase PD, Billman GE, Janse MJ et al. 2013 The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias. Pharmacology & Therapeutics 139 213-248. (doi:10.1016/j.pharmthera.2013.04.008).
15. Ducimetiere P, Eschwege E, Papoz L, Richard J, Claude J & Rosselin G 1980 Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19 205-210.
16. Earnshaw WC, Martins LM & Kaufmann SH 1999 Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annual Review of Biochemistry 68 383-424. (doi:10.1146/annurev. biochem.68.1.383).
17. El-Sherbeeny NA & Nader MA 2016 The protective effect of vildagliptin in chronic experimental cyclosporine A-induced hepatotoxicity. Canadian Journal of Physiology and Pharmacology 94 251-256. (doi:10.1139/cjpp-2015-0336).
18. Espinola-Klein C, Gori T, Blankenberg S & Munzel T 2011 Inflammatory markers and cardiovascular risk in the metabolic syndrome. Frontiers in Biosciences 16 1663-1774. (doi:10.2741/3812).
19. Flegal KM, Carroll MD, Kit BK & Ogden CL 2012 Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307 491-497. (doi:10.1001/jama.2012.39).
20. Foley PL 2005 Common surgical procedures in rodents. In Laboratory Animal Medicine and Management. Eds JD Reuter & MA Suckow. Office of Animal Research Education and Compliance, University of Virginia, Charlottesville, VA, USA: International Veterinary Information Service, Ithaca, NY, USA. (www.ivis.org).
21. Francomano D, Bruzziches R, Barbaro G, Lenzi A & Aversa A 2014 Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study. Journal of Endocrinological Investigation 37 401-411. (doi:10.1007/s40618-014-0066-9).
22. Friedewald WT, Levy RI & Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18 499-502.
23. Garrido P, Salehzadeh F, Duque-Guimaraes DE & Al-Khalili L 2014 Negative regulation of glucose metabolism in human myotubes by supraphysiological doses of 17beta-estradiol or testosterone. Metabolism 63 1178-1187. (doi:10.1016/j.metabol.2014.06.003).
24. Giannocco G, Oliveira KC, Crajoinas RO, Venturini G, Salles TA, Fonseca-Alaniz MH, Maciel RM & Girardi AC 2013 Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats. European Journal of Pharmacology 698 74-86. (doi:10.1016/j.ejphar.2012.09.043).
25. Glorie LL, Verhulst A, Matheeussen V, Baerts L, Magielse J, Hermans N, D'Haese PC, De Meester I & De Beuf A 2012 DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury. American Journal of Physiology: Renal Physiology 303 F681-F688. (doi:10.1152/ajprenal.00075.2012).
26. Halestrap AP & Pasdois P 2009 The role of the mitochondrial permeability transition pore in heart disease. Biochimica et Biophysica Acta 1787 1402-1415. (doi:10.1016/j.bbabio.2008.12.017).
27. Handelsman DJ & Zajac JD 2004 Androgen deficiency and replacement therapy in men. Medical Journal of Australia 180 529-535.
28. Hausenloy DJ, Duchen MR & Yellon DM 2003 Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovascular Research 60 617-625. (doi:10.1016/j.cardiores.2003.09.025).
29. Huang C, Gu H, Zhang W, Herrmann JL & Wang M 2010 Testosteronedown-regulated Akt pathway during cardiac ischemia/reperfusion: a mechanism involving BAD, Bcl-2 and FOXO3a. Journal of Surgical Research 164 e1-e11. (doi:10.1016/j.jss.2010.07.041).
30. Huisamen B, Genis A, Marais E & Lochner A 2011 Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats. Cardiovascular Drugs Therapy 25 13-20. (doi:10.1007/s10557-010-6271-7).
31. Hwang TI, Liao TL, Lin JF, Lin YC, Lee SY, Lai YC & Kao SH 2011 Low-dose testosterone treatment decreases oxidative damage in TM3 Leydig cells. Asian Journal of Andrology 13 432-437. (doi:10.1038/aja.2010.159).
32. Ishii M, Shibata R, Kondo K, Kambara T, Shimizu Y, Tanigawa T, Bando YK, Nishimura M, Ouchi N & Murohara T 2014 Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism. Journal of Biological Chemistry 289 27235-27245. (doi:10.1074/jbc.M114.557835).
33. Kelly DM & Jones TH 2013 Testosterone: a vascular hormone in health and disease. Journal of Endocrinology 217 R47-R71. (doi:10.1530/joe-12-0582).
34. Krishnamoorthy A, Greiner MA, Bertoni AG, Eapen ZJ, O'Brien EC, Curtis LH, Hernandez AF & Mentz RJ 2016 The obesity and heart failure epidemics among African Americans: insights from the Jackson Heart Study. Journal of Cardiac Failure 22 589-597. (doi:10.1016/j.cardfail.2016.03.004).
35. Lateef A, Khan AQ, Tahir M, Khan R, Rehman MU, Ali F, Hamiza OO & Sultana S 2013 Androgen deprivation by flutamide modulates uPAR, MMP-9 expressions, lipid profile, and oxidative stress: amelioration by daidzein. Molecular and Cellular Biochemistry 374 49-59. (doi:10.1007/s11010-012-1504-7).
36. Lu MC, Tzang BS, Kuo WW, Wu FL, Chen YS, Tsai CH, Huang CY & Lee SD 2007 More activated cardiac mitochondrial-dependent apoptotic pathway in obese Zucker rats. Obesity 15 2634-2642. (doi:10.1038/oby.2007.315).
37. Lu SF, Huang Y, Wang N, Shen WX, Fu SP, Li Q, Yu ML, Liu WX, Chen X, Jing XY et al. 2016 Cardioprotective effect of electroacupuncture pretreatment on myocardial ischemia/reperfusion injury via antiapoptotic signaling. Evidence-Based Complementary and Alternative Medicine 2016 4609784. (doi:10.1155/2016/4609784).
38. Mancini A, Leone E, Festa R, Grande G, Silvestrini A, de Marinis L, Pontecorvi A, Maira G, Littarru GP & Meucci E 2008 Effects of testosterone on antioxidant systems in male secondary hypogonadism. Journal of Andrology 29 622-629. (doi:10.2164/jandrol.107.004838).
39. Maruyama D, Hirata N, Tokinaga Y, Kawaguchi R & Yamakage M 2016 Nitrite reduces ischemia-induced ventricular arrhythmias by attenuating connexin 43 dephosphorylation in rats. Anesthesia and Analgesia 122 410-417. (doi:10.1213/ANE.0000000000001063).
40. Ogden CL, Carroll MD, Fryar CD & Flegal KM 2015 Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief 1-8.
41. Peterson QP, Hsu DC, Goode DR, Novotny CJ, Totten RK & Hergenrother PJ 2009 Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3. Journal of Medicinal Chemistry 52 5721-5731. (doi:10.1021/jm900722z).
42. Pintana H, Pongkan W, Pratchayasakul W, Chattipakorn N & Chattipakorn SC 2015 Testosterone replacement attenuates cognitive decline in testosterone-deprived lean rats, but not in obese rats, by mitigating brain oxidative stress. Age 37 84. (doi:10.1007/s11357-015-9827-4).
43. Pongkan W, Chattipakorn SC & Chattipakorn N 2015 Chronic testosterone replacement exerts cardioprotection against cardiac ischemia-reperfusion injury by attenuating mitochondrial dysfunction in testosterone-deprived rats. PLoS ONE 10 e0122503. (doi:10.1371/journal.pone.0122503).
44. Pongkan W, Pintana H, Sivasinprasan S, Jaiwongkam T, Chattipakorn N & Chattipakorn SC 2016 Testosterone deprivation accelerates cardiac dysfunction in obese male rats. Journal of Endocrinology 229 209-220. (doi:10.1530/JOE-16-0002).
45. Pratchayasakul W, Kerdphoo S, Petsophonsakul P, Pongchaidecha A, Chattipakorn N & Chattipakorn SC 2011 Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone. Life Science 88 619-627. (doi:10.1016/j.lfs.2011.02.003).
46. Reckelhoff JF, Yanes LL, Iliescu R, Fortepiani LA & Granger JP 2005 Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. American Journal of Physiology: Renal Physiology 289 F941-F948. (doi:10.1152/ajprenal.00034.2005).
47. Rottman JN, Ni G & Brown M 2007 Echocardiographic evaluation of ventricular function in mice. Echocardiography 24 83-89. (doi:10.1111/j.1540-8175.2006.00356.x).
48. Traish AM & Kypreos KE 2011 Testosterone and cardiovascular disease: an old idea with modern clinical implications. Atherosclerosis 214 244-248. (doi:10.1016/j.atherosclerosis.2010.08.078).
49. Traish AM, Saad F & Guay A 2009 The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. Journal of Andrology 30 23-32. (doi:10.2164/jandrol.108.005751).
50. Traish AM, Haider A, Doros G & Saad F 2014 Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. International Journal of Clinical Practice 68 314-329. (doi:10.1111/ijcp.12319).
51. Valle MM, Graciano MF, Lopes de Oliveira ER, Camporez JP, Akamine EH, Carvalho CR, Curi R & Carpinelli AR 2011 Alterations of NADPH oxidase activity in rat pancreatic islets induced by a high-fat diet. Pancreas 40 390-395. (doi:10.1097/MPA.0b013e31820569d0).
52. Walters J, Pop C, Scott FL, Drag M, Swartz P, Mattos C, Salvesen GS & Clark AC 2009 A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochemical Journal 424 335-345. (doi:10.1042/BJ20090825).
53. Wu FC & von Eckardstein A 2003 Androgens and coronary artery disease. Endocrine Reviews 24 183-217. (doi:10.1210/er.2001-0025).
54. Zhang L, Lei D, Zhu GP, Hong L & Wu SZ 2013 Physiological testosterone retards cardiomyocyte aging in Tfm mice via androgen receptorindependent pathway. Chinese Medical Sciences Journal 28 88-94. (doi:10.1016/S1001-9294(13)60028-0).